Prevalence of herpes simplex virus type 2 in different risk groups: Thirty years after the onset of HIV

Intervirology

Volumn 55, Issue 6, 2012, Pages 395-400

  Reinheimer, Claudia ^a   Doerr, Hans W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Germany; Herpes genitalis; HIV; HSV2; Seroepidemiology

Indexed keywords

HERPES SIMPLEX VIRUS 2 IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; DERMATOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GYNECOLOGY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2 INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; SEROPREVALENCE; SEX RATIO;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

HERPES; HUMAN HERPESVIRUS 2;

EID: 84867233189     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000336659     Document Type: Article

References (31)

1. Buxbaum S, Geers M, Gross G, Schöfer H, Rabenau HF, Doerr HW: Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed? Med Microbiol Immunol 2003; 192: 177-181.
2. World Health Organization: Herpes simplex virus type 2 programmatic and research priorities in developing countries. WHO/HIV/AIDS/2001.05. Report of a WHO/UNAIDS/LSHTM Workshop, London 2001.
3. Gupta R, Warren T, Wald A: Genital herpes. Lancet 2007; 370: 2127-2137.
4. Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A: Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011; 305: 1441-1449.
5. Phipps W, Saracino M, Magaret A, Selke S, Remington M, Huang ML, Warren T, Casper C, Corey L, Wald A: Persistent genital herpes simplex virus-2 shedding years following the first clinical episode. J Infect Dis 2011; 203: 180-187.
6. Brown AS, Derkits EJ: Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010; 167: 261-280.
7. Buka SL, Cannon TD, Torrey EF, Yolken RH, Collaborative Study Group on the Perinatal Origins of Severe Psychiatric Disorders: Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 2008; 63: 809-815.
8. Mortensen PB, Pedersen CB, Hougaard DM, Nørgaard-Petersen B, Mors O, Børglum AD, Yolken RH: A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res 2010; 122: 257-263.
9. Brown AS, Schaefer CA, Quesenberry CP Jr, Shen L, Susser ES: No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia? Am J Psychiatry 2006; 163: 2178-2180.
10. Abu-Raddad LJ, Margaret AS, Celum C, et al: Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One 2008; 3:e2230.
11. Freeman EE, Weiss HA, Glynn JR, et al: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83.
12. Pouget ER, Kershaw TS, Blankenship KM, Ickovics JR, Niccolai LM: Racial/ethnic disparities in undiagnosed infection with herpes simplex virus type 2. Sex Transm Dis 2010; 37: 538-543.
13. Martinelli E, Tharinger H, Frank I, Arthos J, Piatak M Jr, Lifson JD, Blanchard J, Gettie A, Robbiani M: HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog 2011; 7:e1002109.
14. Reinheimer C, Allwinn R, Berger A: Hepatitis E: Are psychiatric patients on special risk? Med Microbiol Immunol 2011 (E-pub ahead of print).
15. Reinheimer C, Allwinn R, Doerr HW: Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010. Infection 2011 (E-pub ahead of print).
16. Gibney L, Saquib N, Macaluso M, Hasan KN, Aziz MM, Khan AY, Choudhury P: Sexually transmitted diseases in Bangladesh's trucking industry: prevalence and risk factors. Sex Transm Infect 2002; 78: 31-36.
17. Clemens SA, Farhat CK: Seroprevalence of herpes simplex 1-2 antibodies in Brazil. Rev Saude Publica 2010; 44: 726-734.
18. Kirakoya-Samadoulougou F, Nagot N, Defer MC, Yaro S, Fao P, Ilboudo F, Langani Y, Meda N, Robert A: Epidemiology of herpes simplex virus type-2 infection in rural and urban Burkina Faso. Sex Transm Dis 2011; 38: 117-123.
19. Sierra CA, Bedoya AM, Paris S, Baena A, Gaviria AM, Rojas CA, Arbelaez MP, Sanchez GI: Prevalence of specific herpes simplex virus-antibodies and associated factors in women of a rural town of Colombia. Trans R Soc Trop Med Hyg 2011; 105: 232-238.
20. Ozouaki F, Ndjoyi-Mbiguino A, Legoff J, Onas IN, Kendjo E, Si-Mohamed A, Mbopi-Kéou FX, Malkin JE, Bélec L: Genital shedding of herpes simplex virus type 2 in childbearing-aged and pregnant women living in Gabon. Int J STD AIDS 2006; 17: 124-127.
21. Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW: Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol 2002; 190: 153-160.
22. Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, Brandstädt A, Rabenau HF: Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 2000; 61: 201-207.
23. Yun H, Park J, Choi I, Kee M, Choi B, Kim S: Prevalence of human papillomavirus and herpes simplex virus type 2 infection in Korean commercial sex workers. J Microbiol Biotechnol 2008; 1: 350-354.
24. Anvikar AR, Rao VG, Savargaonkar DD, Rajiv Y, Bhondeley MK, Tiwari B, Karkare A, Luke C, Gadge V, Ukey M, Patel P: Seroprevalence of sexually transmitted viruses in the tribal population of Central India. Int J Infect Dis 2009; 13: 37-39.
25. Davies SC, Taylor JA, Sedyaningsih-Mamahit ER, Gunawan S, Cunningham AL, Mindel A: Prevalence and risk factors for herpes simplex virus type 2 antibodies among lowand high-risk populations in Indonesia. Sex Transm Dis 2007; 34: 132-138.
26. Davidovici BB, Green M, Marouni MJ, Bassal R, Pimenta JM, Cohen D: Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel. J Infect 2006; 52: 367-373.
27. Bohl DD, Katz KA, Bernstein K, Wong E, Raymond HF, Klausner JD, McFarland W: Prevalence and correlates of herpes simplex virus type-2 infection among men who have sex with men, San Francisco, 2008. Sex Transm Dis 2011 (E-pub ahead of print).
28. Bahrdt B, Rabenau HF, Weber B, Eibner J, Doerr HW: Prevalence of herpes simplex virus type 2 specific antibodies in patients with different risks of infection. Z Hautkr 1992; 67: 56-58.
29. Heininger U, Desgrandchamps D, Schaad UB: Seroprevalence of varicella zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine 2006; 24: 3258-3260.
30. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P: Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 2010; 340:c1626.
31. Leuridan E, Hens N, Hutse V, Aerts M, Van Damme P: Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine 2011; 29: 2222-2226.